Immunovant Inc

NASDAQ:IMVT   12:34:34 PM EDT
8.10
+0.27 (+3.45%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Immunovant Inc Stock, NASDAQ:IMVT

320 West 37th Street, 6th floor, New York, New York 10018
United States of America
Phone: +1.917.580.3099
Number of Employees:

Description

Immunovant, Inc. is a clinical-stage biopharmaceutical company. The firm focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded in 2018 and is headquartered in New York, NY.